Skip to main content
Log in

Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction

  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

The expression of transferrin receptor (Tr) was investigated by means of immunohistochemistry in 101 tumours of the human central and peripheral nervous system. The results were compared with the proliferative activity of the tumours, determined by immunostaining for the proliferation-associated antigen Ki-67. In addition to immunostaining of normal and proliferated blood vessel endothelium and of a fraction of tumour infiltrating lymphocytes, we observed staining for Tr in a variable fraction of neoplastic cells of all histological tumour types. Immunoreactivity in the majority of tumour cells was found only in anaplastic tumours such as glioblastomas. Furthermore, a positive correlation between Tr expression and the Ki-67 growth fraction was established for gliomas. Non-glial tumours strongly expressing Tr included one metastatic rhabdomyosarcoma, one intracerebral malignant lymphoma, two of four plasmocytomas and seven of nine metastatic carcinomas. Our results indicate that immunohistochemistry for Tr and Ki-67 can provide additional information about the biological behaviour of nervous system tumours, thus complementing conventional histopathological criteria for anaplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barnett D, Wilson GA, Lawrence AC, Buckley GA (1987) Transferrin receptor expression in the leukaemias and lymphoproliferative disorders. Clin Lab Haematol 9:361–370

    Google Scholar 

  • Colombatti M, Bisconti M, Dell'Arciprete L, Gerosa MA, Tridente G (1988) Sensitivity of human glioma cells to cytotoxic heteroconjugates. Int J Cancer 42:441–448

    Google Scholar 

  • Dautry-Varsat A, Ciechanover A, Lodish HG (1983) pH and the recycling of transferrin during receptor mediated endocytosis. Proc Natl Acad Sci USA 80:2258–2262

    Google Scholar 

  • Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115:179–188

    Google Scholar 

  • Doria MI Jr, Montag AG, Franklin WA (1988) Immunophenotype of small cell lung carcinoma. Expression of NKH-1 and transferrin receptor and absence of most myeloid antigens. Cancer 62:1939–1945

    Google Scholar 

  • Gatter KC, Brown G, Trowbridge IS, Woolston R-E, Mason DY (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539–535

    Google Scholar 

  • Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20

    Google Scholar 

  • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715

    Google Scholar 

  • Hamilton TA (1982) Regulation of transferrin receptor expression in concanavalian A stimulated and Gross virus transformed rat lymphoblasts. J Cell Physiol 113:40–46

    Google Scholar 

  • Hsu SM, Raine L, Fanger H (1981) The use of anti-avidin antibody and avidin-biotin-peroxidase-complex in immunoperoxidase techniques. Am J Clin Pathol 75:816–821

    Google Scholar 

  • Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin receptor on endothelial cells of brain capillaries. Nature 312:162–163

    Google Scholar 

  • Johnson VG, Wrobel C, Wilson D, Zovickian J, Greenfield L, Oldfield EH, Youle R (1989) Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. J Neurosurg 70:240–248

    Google Scholar 

  • Klausner RD, Ashwell G, Renswoude J van, Harford JB, Bridges KR (1983a) Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 80:2263–2266

    Google Scholar 

  • Klausner RD, Renswoude J van, Ashwell G, Kempf C, Schechter AN, Dean A, Bridges KR (1983b) Receptor mediated endocytosis of transferrin in K562 cells. J Biol Chem 258:4715–4724

    Google Scholar 

  • Kleihues P, Meer L, Shibata T, Bamberg M (1988) DNA-Reparatur und DNA-Replikation als Kriterien für therapeutische Effizienz. In: Bamberg S, Sack H (eds) Therapie primärer Hirntumoren, Zuckschwerdt, Munich, pp 1–8

    Google Scholar 

  • Kvaloy S, Langholm R, Kaalhus O, Michaelsen T, Funderud S, Foss Abrahamsen A, Godal T (1984) Transferrin receptor and B-lymphoblast antigen: their relationship to DNA synthesis, histology and survival in B-cell lymphomas. Int J Cancer 33:173–177

    Google Scholar 

  • Larrick JW, Creswell P (1979) Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct 11:579–586

    Google Scholar 

  • Neckers LM, Yenokida G, James SP (1984) The role of transferrin receptor in human B lymphocyte activation. J Immunol 133:2437–2441

    Google Scholar 

  • Niitsu Y, Kohgo Y, Nishisato T, Kondo H, Kato J, Urushizaki Y, Urushizaki I (1987) Transferrin receptors in human cancerous tissues. Tohoku J Exp Med 153:239–243

    Google Scholar 

  • Medeiros LJ, Picker LJ, Horning SJ, Warnke RA (1988) Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival. Cancer 61:1844–1851

    Google Scholar 

  • Prior R, Reifenberger G, Wechsler W (1989) Nerve growth factor receptor in tumours of the human nervous system. Immunohistochemical analysis of receptor expression and tumour growth fraction. Pathol Res Pract 185:332–338

    Google Scholar 

  • Reifenberger G, Prior R, Deckert M, Wechsler W (1989) Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch [A] 414:147–155

    Google Scholar 

  • Schneider C, Sutherland R, Newman R, Greaves M (1982) Structural features of the cell surface receptor for transferrin that is recognised by the monoclonal antibody OKT9. J Biol Chem 257:8516–8522

    Google Scholar 

  • Schneider C, Owen M, Banville D, Williams JG (1984) Primary structure of human transferrin receptor deduced from the mRNA sequence Nature 311:675–678

    Google Scholar 

  • Schrape S, Jones DB, Wright DH (1987) A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma. Br J Cancer 55:283–286

    Google Scholar 

  • Sciot R, Paterson AC, Eyken P van, Callea F, Kew MC, Desmet VJ (1988) Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology 12:53–63

    Google Scholar 

  • Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA (1987) Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 15:341–344

    Google Scholar 

  • Soyer HP, Smolle J, Torne R, Kerl H (1987) Transferrin receptor expression in normal skin and in various cutaneous tumors. J Cutan Pathol 14:1–5

    Google Scholar 

  • Trowbridge IS, Newman RA, Domingo DL, Sauvage C (1984) Transferrin receptors: structure and function. Biochem Pharmacol 33:925–932

    Google Scholar 

  • Wain SL, Braylan RC, Borowitz MJ (1987) Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience. Cancer 60:2403–24

    Google Scholar 

  • Walker RA, Camplejohn RS (1986) DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150:37–42

    Google Scholar 

  • Winkler J, Roosen N, Reifenberger G, Wechsler W (1988) Dedifferentiation in recurrent astrocytoma: clinicopathological study of two cases (abstract). Clin Neuropathol 7:222

    Google Scholar 

  • Wrba F, Ritzinger E, Reiner A, Holzner JH (1986) Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study. Virchows Arch [A] 410:69–73

    Google Scholar 

  • Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J (1988) Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract 183:277–283

    Google Scholar 

  • Zovickian J, Johnson VG, Youle RJ (1987) Potent and specific killing of human malignant brain tumor cells by an antitransferrin receptor antibody-ricin immunotoxin. J Neurosurg 66:850–861

    Google Scholar 

  • Zülch KJ (1979) Histological typing of tumours of the central nervous system. International histological classification of tumours. WHO, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prior, R., Reifenberger, G. & Wechsler, W. Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction. Vichows Archiv A Pathol Anat 416, 491–496 (1990). https://doi.org/10.1007/BF01600299

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01600299

Key words

Navigation